Expression profiling and putative mechanisms of resistance to doxorubicin of human lung cancer cells

Dokl Biochem Biophys. 2010 Jan-Feb:430:20-3. doi: 10.1134/s1607672910010072.

Authors

K N Kashkin¹, E A Musatkina, A V Komelkov, I A Favorskaya, E V Trushkin, V A Shleptsova, D A Sakharov, T V Vinogradova, E P Kopantzev, M V Zinovyeva, O V Kovaleva, I B Zborovskaya, A G Tonevitsky, E D Sverdlov

Affiliation

¹ Shemyakin-Ovchinnikov Institute of Bioorganic Chemistry, Russian Academy of Sciences, ul. Miklukho-Maklaya 16/10, Moscow, 117997 Russia.

PMID: 20380156
DOI: 10.1134/s1607672910010072

No abstract available

Publication types

Research Support, Non-U.S. Gov't

MeSH terms

Antineoplastic Agents / pharmacology*
Biomarkers, Tumor / genetics
Cell Line, Tumor
Doxorubicin / pharmacology*
Drug Resistance, Neoplasm / genetics*
Gene Expression Profiling*
Gene Expression Regulation, Neoplastic / drug effects
Gene Expression Regulation, Neoplastic / genetics
Humans
Lung Neoplasms / genetics*
Lung Neoplasms / pathology*
Signal Transduction

Substances

Antineoplastic Agents
Biomarkers, Tumor
Doxorubicin